Cost Analysis of Enhancing Linkages to HIV Care Following Jail: a Cost-effective Intervention

Overview

Journal AIDS Behav

Specialty Infectious Diseases

Date 2012 Nov 10

PMID 23138877

Citations 10

Authors

Anne C Spaulding

Steven D Pinkerton

Hillary Superak

Marc J Cunningham

Stephen Resch

Alison O Jordan

Zhou Yang

Affiliations

Soon will be listed here.

Abstract

We are not aware of published cost-effectiveness studies addressing community transitional programs for HIV-infected jail detainees. To address this gap, data from 9 sites of EnhanceLink, a project that enrolled HIV-infected releasees from jails across the US, were examined. Figures on the number of clients served, cost of linkage services, number of linkages and 6-month sustained linkages to community HIV care, and number of clients achieving viral suppression were assessed for subjects released in the first quarter of 2010 (n = 543). The cost analysis included all costs that participating service agencies incurred. A cost-effectiveness analysis was conducted to estimate the new HIV cases averted by EnhanceLink and the cost per quality-adjusted life year saved by the program. The mean cost per linked client was $4,219; the mean cost per 6-month sustained linkage was $4,670; and the mean cost per client achieving viral suppression was $8,432. Compared to standard care, the cost per additional quality-adjusted life year saved was $72,285, suggesting that the EnhanceLink interventions were cost-effective from the societal perspective.

Citing Articles

Modeling as Visioning: Exploring the Impact of Criminal Justice Reform on Health of Populations with Substance Use Disorders.

Martin N, Beletsky L, Linas B, Bayoumi A, Pollack H, Larney S MDM Policy Pract. 2023; 8(2):23814683231202984.

PMID: 37841498 PMC: 10568988. DOI: 10.1177/23814683231202984.

Cost savings of a primary care program for individuals recently released from prison: a propensity-matched study.

Harvey T, Busch S, Lin H, Aminawung J, Puglisi L, Shavit S BMC Health Serv Res. 2022; 22(1):585.

PMID: 35501855 PMC: 9059905. DOI: 10.1186/s12913-022-07985-5.

The Cost-Effectiveness of HIV/STI Prevention in High-Income Countries with Concentrated Epidemic Settings: A Scoping Review.

Brunner P, Brunner K, Kubler D AIDS Behav. 2022; 26(7):2279-2298.

PMID: 35034238 PMC: 9163023. DOI: 10.1007/s10461-022-03583-y.

Outcomes and costs of publicly funded patient navigation interventions to enhance HIV care continuum outcomes in the United States: A before-and-after study.

Shade S, Kirby V, Stephens S, Moran L, Charlebois E, Xavier J PLoS Med. 2021; 18(5):e1003418.

PMID: 33983925 PMC: 8118317. DOI: 10.1371/journal.pmed.1003418.

Jail, an unappreciated medical home: Assessing the feasibility of a strengths-based case management intervention to improve the care retention of HIV-infected persons once released from jail.

Spaulding A, Drobeniuc A, Frew P, Lemon T, Anderson E, Cerwonka C PLoS One. 2018; 13(3):e0191643.

PMID: 29601591 PMC: 5877830. DOI: 10.1371/journal.pone.0191643.

References

Shrestha R, Sansom S, Richardson-Moore A, French P, Scalco B, LaLota M . Costs of voluntary rapid HIV testing and counseling in jails in 4 states--advancing HIV Prevention Demonstration Project, 2003-2006. Sex Transm Dis. 2009; 36(2 Suppl):S5-8. DOI: 10.1097/olq.0b013e318148b69f. View

. HIV surveillance--United States, 1981-2008. MMWR Morb Mortal Wkly Rep. 2011; 60(21):689-93. View

Pinkerton S . HIV transmission rate modeling: a primer, review, and extension. AIDS Behav. 2011; 16(4):791-6. PMC: 4103007. DOI: 10.1007/s10461-011-0042-8. View

Draine J, Ahuja D, Altice F, Arriola K, Avery A, Beckwith C . Strategies to enhance linkages between care for HIV/AIDS in jail and community settings. AIDS Care. 2011; 23(3):366-77. DOI: 10.1080/09540121.2010.507738. View

Prejean J, Song R, Hernandez A, Ziebell R, Green T, Walker F . Estimated HIV incidence in the United States, 2006-2009. PLoS One. 2011; 6(8):e17502. PMC: 3149556. DOI: 10.1371/journal.pone.0017502. View

Gebo K, Fleishman J, Conviser R, Hellinger J, Hellinger F, Josephs J . Contemporary costs of HIV healthcare in the HAART era. AIDS. 2010; 24(17):2705-15. PMC: 3551268. DOI: 10.1097/QAD.0b013e32833f3c14. View

Marks G, Crepaz N, Janssen R . Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS. 2006; 20(10):1447-50. DOI: 10.1097/01.aids.0000233579.79714.8d. View

Farnham P, Sansom S, Hutchinson A . How much should we pay for a new HIV diagnosis? A mathematical model of HIV screening in US clinical settings. Med Decis Making. 2012; 32(3):459-69. DOI: 10.1177/0272989X11431609. View

Westergaard R, Kirk G, Richesson D, Galai N, Mehta S . Incarceration predicts virologic failure for HIV-infected injection drug users receiving antiretroviral therapy. Clin Infect Dis. 2011; 53(7):725-31. PMC: 3202322. DOI: 10.1093/cid/cir491. View

10.

Holtgrave D, Hall H, Rhodes P, Wolitski R . Updated annual HIV transmission rates in the United States, 1977-2006. J Acquir Immune Defic Syndr. 2009; 50(2):236-8. DOI: 10.1097/qai.0b013e31819001be. View

11.

Pinkerton S . How many sexually-acquired HIV infections in the USA are due to acute-phase HIV transmission?. AIDS. 2007; 21(12):1625-9. PMC: 2377417. DOI: 10.1097/QAD.0b013e32826fb6a6. View

12.

. Vital signs: HIV prevention through care and treatment--United States. MMWR Morb Mortal Wkly Rep. 2011; 60(47):1618-23. View

13.

Schackman B, Gebo K, Walensky R, Losina E, Muccio T, Sax P . The lifetime cost of current human immunodeficiency virus care in the United States. Med Care. 2006; 44(11):990-7. DOI: 10.1097/01.mlr.0000228021.89490.2a. View

14.

Hutchinson A, Farnham P, Dean H, Ekwueme D, Del Rio C, Kamimoto L . The economic burden of HIV in the United States in the era of highly active antiretroviral therapy: evidence of continuing racial and ethnic differences. J Acquir Immune Defic Syndr. 2006; 43(4):451-7. DOI: 10.1097/01.qai.0000243090.32866.4e. View

15.

Marks G, Crepaz N, Senterfitt J, Janssen R . Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr. 2005; 39(4):446-53. DOI: 10.1097/01.qai.0000151079.33935.79. View

16.

Spaulding A, Seals R, Page M, Brzozowski A, Rhodes W, Hammett T . HIV/AIDS among inmates of and releasees from US correctional facilities, 2006: declining share of epidemic but persistent public health opportunity. PLoS One. 2009; 4(11):e7558. PMC: 2771281. DOI: 10.1371/journal.pone.0007558. View

17.

Cohen M, Chen Y, McCauley M, Gamble T, Hosseinipour M, Kumarasamy N . Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011; 365(6):493-505. PMC: 3200068. DOI: 10.1056/NEJMoa1105243. View

18.

Quinn T, Wawer M, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F . Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med. 2000; 342(13):921-9. DOI: 10.1056/NEJM200003303421303. View

19.

Gardner L, Metsch L, Anderson-Mahoney P, Loughlin A, Del Rio C, Strathdee S . Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS. 2005; 19(4):423-31. DOI: 10.1097/01.aids.0000161772.51900.eb. View